Clinical Radiology
Volume 63, Issue 10 , Pages 1136-1141 , October 2008

Can catheter-directed thrombolysis be applied to acute lower extremity artery embolism after recent cerebral embolism from atrial fibrillation?

  • T.-G. Si
    • ,
  • Z. Guo

      Affiliations

    • Corresponding Author InformationGuarantor and correspondent: Z. Guo, Department of interventional treatment, Tianjin medical university cancer Hospital and Institution, Huanhuxi Road, Hexi District, Tianjin 300060, China. Tel.: +86 22 23340123x2401; fax: +86 22 23359337.
    • ,
  • X.-S. Hao

Received 5 October 2007 ,Revised 19 April 2008 ,Accepted 22 April 2008.

References 

  1. Ouriel K, Veith FJ, Sasahara AA. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. N Engl J Med. 1998;338:1105–1111
  2. The STILE investigators. Results of a prospective randomized trial evaluation surgery versus thrombolysis for ischemia of the lower extremity: the STILE trial. Ann Surg. 1994;220:251–266
  3. Patel N, Sacks D, Patel RI, et al. SCVIR reporting standards for the treatment of acute limb ischemia with use of transluminal removal of arterial thrombus. J Vasc Interv Radiol. 2001;12:559–570
  4. Marini C, De Santis F, Sacco S, et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke. Stroke. 2005;36:1115–1119
  5. Rutherford RB, Flanigan DP, Gupta SF, et al. Suggested standards for reports dealing with lower extremity ischaemia. J Vasc Surg. 1986;4:80–94
  6. Owens W, Felts J, Spitznagel E. ASA physical status classification: a study of consistency of ratings. Anesthesiology. 1978;49:239–243
  7. Hart RG, Santiago Palacio S, Pearce LA. Atrial fibrillation, stroke, and acute antithrombotic therapy: analysis of randomized clinical trials. Stroke. 2002;33:2722–2727
  8. Decrinis M, Pilger E, Stark G, et al. A simplified procedure for intra-arterial thrombolysis with tissue-type plasminogen activator in peripheral arterial occlusive disease: primary and long-term results. Eur Heart J. 1993;14:297–305
  9. Castaneda F, Swischuk JL, Li R, et al. Declining-dose study of reteplase treatment for lower extremity arterial occlusions. J Vasc Interv Radiol. 2002;13:1093–1098
  10. McNamara TO, Dong P, Chen J, et al. Bleeding complications associated with the use of rt-PA versus r-PA for peripheral arterial and venous thromboembolic occlusions. Tech Vasc Interv Radiol. 2001;4:92–98
  11. Davidian MM, Powell A, Benenati JF, et al. Initial results of reteplase in the treatment of acute lower extremity arterial occlusions. J Vasc Interv Radiol. 2000;11:289–294
  12. Ouriel K, Katzen B, Mewissen M, et al. Reteplase in the treatment of peripheral arterial and venous occlusions: a pilot study. J Vasc Interv Radiol. 2000;11:849–854
  13. Castaneda F, Li R, Young K, et al. Catheter-directed thrombolysis in deep venous thrombosis with use of reteplase: immediate results and complications from a pilot study. J Vasc Interv Radiol. 2002;13:577–580
  14. Ward AS, Andaz SK, Bygrave S. Peripheral thrombolysis with tissue plasminogen activator: results of two treatment regimens. Arch Surg. 1994;129:861–865
  15. Braithwaite BD, Buckenham TM, Galland RB, et al. Prospective randomized trial of high-dose versus low-dose tissue plasminogen activator infusion in the management of acute limb ischaemia. Thrombolysis Study Group. Br J Surg. 1997;84:646–650
  16. Kaplan RC, Tirschwell DL, Longstreth WT, et al. Vascular events, mortality, and preventive therapy following ischemic stroke in the elderly. Neurology. 2005;65:835–842
  17. Patel SC, Mody A. Cerebral hemorrhagic complications of thrombolytic therapy. Prog Cardiovasc Dis. 1999;42:217–233
  18. The Interventional Management of Stroke Study Investigators . Hemorrhage in the interventional management of stroke study. Stroke. 2006;37:847–851
  19. Hamann GF, Okada Y, del Zoppo GJ. Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion. J Cereb Blood Flow Metab. 1996;16:1373–1378
  20. Castellanos M, Leira R, Serena J, et al. Plasma cellular fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke. Stroke. 2004;35:1671–1676
  21. Rodriguez-Yanez M, Castellanos M, Blanco M, et al. Micro- and macroalbuminuria predict hemorrhagic transformation in acute ischemic stroke. Neurology. 2006;67:1172–1177

PII: S0009-9260(08)00205-5

doi: 10.1016/j.crad.2008.04.014

Clinical Radiology
Volume 63, Issue 10 , Pages 1136-1141 , October 2008

Article Tools

* Image Usage & Resolution